The CASE for Hemispherx Biopharma. DRUGS for the gambler!
June 04, 2009
– Comments (20) |
RELATED TICKERS: HEB
I'm a switch hitter. Yes, I turn with the tide.
Hemispherx became inflated from swine flue wannabe and FDA approval/denial for a Ampligen(r)), for Chronic Fatigue Syndrome. They have tounted Ampligen as a cure for everything for ten years now with no success. Sorta like Dr. Carter's little liver pills. Besides FDA approval pending for CFS, a Japanese based partner has been indicating that Ampligen is " "most promising adjuvant candidate for mucosal vaccines." (read, taking it through the nose, instead of the arm where it's less effective). It can also be used to "water down" the serum and stretch it further. Which is important when you may have multiple vaccines this year. (Aka H1N1, H5N1, and any variants that might arise). Since it had not been tested for the flu and no trials in place, I had discounted this option, but the Japanese are serious about getting any tool available they can before another pandemic.
When FDA approval did not come on schedule for CFS, I was also suspicious. Hemispherx indicated that the FDA had requested a one to two week delay on a reply. This seemed "fishy" to me. It does appear that the FDA and Hemispherx have been rubbing elbows at a conference in Italy, so are indeed both "busy.
In the meantime hemispherx has been popping in stages. Is it a weapon against flu variations? Is it help for CFS which has been questioned as an "actual disease"? Is it a cure for the gout, arthritis, or a Cialis replacement? I really don't know, but it's popping and I'm riding. We will see what's left when this one deflates.
I lucked out on a small portion of DNDN. I lost out on Northfield Laboratories (NFLD)
Bios are drug stocks, and playing them can be addictive. You can see them popping and dropping. People running from one to the next. Very few make the grade with the FDA. Many get sent back for more data, disapproved on the spot, end up with dangerous side effects, or management just stinks. Most pops are the herd following too late.
I can't say what will happen with HEB. I have my doubts after all these years. The double option of antiviral or CFS means this could posibly stay up above my buy price if one falls through. It could really pop if both hit. But it could all turn to air just as easily.
FOOLS go where others fear to tread...or are too smart to fall in.
Don't play bios/pharma like FAS and FAZ, but on a small scale, it's cheap drugs for the mind/soul and worth some fun.
Good luck.
RSS Headlines
Fool UK